▶ 調査レポート

世界の唾液腺感染市場:市場規模・現状・予測

• 英文タイトル:Global Salivary Gland Infection Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の唾液腺感染市場:市場規模・現状・予測 / Global Salivary Gland Infection Market Size, Status and Forecast 2019-2025 / QYR9N7991資料のイメージです。• レポートコード:QYR9N7991
• 出版社/出版日:QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、唾液腺感染のグローバル市場について調査・分析したレポートで、種類別(診断、治療)、用途別(病院、診療所、家庭、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・唾液腺感染の世界市場規模
・主要企業別市場シェア
・唾液腺感染の世界市場規模:種類別(診断、治療)
・唾液腺感染の世界市場規模:用途別(病院、診療所、家庭、その他)
・唾液腺感染のアメリカ市場規模(種類別、用途別)
・唾液腺感染のヨーロッパ市場規模(種類別、用途別)
・唾液腺感染の中国市場規模(種類別、用途別)
・唾液腺感染の日本市場規模(種類別、用途別)
・唾液腺感染の東南アジア市場規模(種類別、用途別)
・唾液腺感染のインド市場規模(種類別、用途別)
・唾液腺感染の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・唾液腺感染の世界市場予測(2019年-2025年)
・唾液腺感染の地域別市場予測(2019年-2025年)
...

Salivary gland infection is one of the most common medical condition across the globe. These infections are mostly caused due to bacteria or viruses. Salivary gland infection affects salivary duct or gland.Considering the global scenario of the market, Americas holds the largest market share due to various factors such as increasing number of patients with various salivary gland infections and related disorders. European salivary gland infection market is the second largest where the west European countries are dominating the largest market share. Prevalence of various salivary gland infection is rising in Asia Pacific region. Additionally, increasing healthcare spending and rapidly changing healthcare sector, and government initiatives to improve public health are major growth drivers for Asia Pacific salivary gland infection market. Due to low knowledge of disease and treatments, low-income, and limited access to healthcare facilities, Middle East and Africa (ME&A) is likely to have a limited growth in the market.
In 2018, the global Salivary Gland Infection market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Salivary Gland Infection status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Salivary Gland Infection development in United States, Europe and China.

The key players covered in this study
AbbVie Inc. (US)
Allergan (Republic of Ireland)
AstraZeneca (UK)
FUJIFILM Holdings Corporation (Japan)
General Electric Company (US)
GlaxoSmithKline plc. (UK)
Johnson & Johnson Services, Inc. (US)
Merck & Co., Inc. (US)
Pfizer Inc.(US)
Siemens Healthcare GmbH (Germany)

Market segment by Type, the product can be split into
Diagnosis
Treatment

Market segment by Application, split into
Hospital
Clinic
Household
Other

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Salivary Gland Infection status, future forecast, growth opportunity, key market and key players.
To present the Salivary Gland Infection development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Salivary Gland Infection are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Salivary Gland Infection Market Size Growth Rate by Type (2014-2025)
1.4.2 Diagnosis
1.4.3 Treatment
1.5 Market by Application
1.5.1 Global Salivary Gland Infection Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Household
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Salivary Gland Infection Market Size
2.2 Salivary Gland Infection Growth Trends by Regions
2.2.1 Salivary Gland Infection Market Size by Regions (2014-2025)
2.2.2 Salivary Gland Infection Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Salivary Gland Infection Market Size by Manufacturers
3.1.1 Global Salivary Gland Infection Revenue by Manufacturers (2014-2019)
3.1.2 Global Salivary Gland Infection Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Salivary Gland Infection Market Concentration Ratio (CR5 and HHI)
3.2 Salivary Gland Infection Key Players Head office and Area Served
3.3 Key Players Salivary Gland Infection Product/Solution/Service
3.4 Date of Enter into Salivary Gland Infection Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Salivary Gland Infection Market Size by Type (2014-2019)
4.2 Global Salivary Gland Infection Market Size by Application (2014-2019)

5 United States
5.1 United States Salivary Gland Infection Market Size (2014-2019)
5.2 Salivary Gland Infection Key Players in United States
5.3 United States Salivary Gland Infection Market Size by Type
5.4 United States Salivary Gland Infection Market Size by Application

6 Europe
6.1 Europe Salivary Gland Infection Market Size (2014-2019)
6.2 Salivary Gland Infection Key Players in Europe
6.3 Europe Salivary Gland Infection Market Size by Type
6.4 Europe Salivary Gland Infection Market Size by Application

7 China
7.1 China Salivary Gland Infection Market Size (2014-2019)
7.2 Salivary Gland Infection Key Players in China
7.3 China Salivary Gland Infection Market Size by Type
7.4 China Salivary Gland Infection Market Size by Application

8 Japan
8.1 Japan Salivary Gland Infection Market Size (2014-2019)
8.2 Salivary Gland Infection Key Players in Japan
8.3 Japan Salivary Gland Infection Market Size by Type
8.4 Japan Salivary Gland Infection Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Salivary Gland Infection Market Size (2014-2019)
9.2 Salivary Gland Infection Key Players in Southeast Asia
9.3 Southeast Asia Salivary Gland Infection Market Size by Type
9.4 Southeast Asia Salivary Gland Infection Market Size by Application

10 India
10.1 India Salivary Gland Infection Market Size (2014-2019)
10.2 Salivary Gland Infection Key Players in India
10.3 India Salivary Gland Infection Market Size by Type
10.4 India Salivary Gland Infection Market Size by Application

11 Central & South America
11.1 Central & South America Salivary Gland Infection Market Size (2014-2019)
11.2 Salivary Gland Infection Key Players in Central & South America
11.3 Central & South America Salivary Gland Infection Market Size by Type
11.4 Central & South America Salivary Gland Infection Market Size by Application

12 International Players Profiles
12.1 AbbVie Inc. (US)
12.1.1 AbbVie Inc. (US) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Salivary Gland Infection Introduction
12.1.4 AbbVie Inc. (US) Revenue in Salivary Gland Infection Business (2014-2019)
12.1.5 AbbVie Inc. (US) Recent Development
12.2 Allergan (Republic of Ireland)
12.2.1 Allergan (Republic of Ireland) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Salivary Gland Infection Introduction
12.2.4 Allergan (Republic of Ireland) Revenue in Salivary Gland Infection Business (2014-2019)
12.2.5 Allergan (Republic of Ireland) Recent Development
12.3 AstraZeneca (UK)
12.3.1 AstraZeneca (UK) Company Details
12.3.2 Company Description and Business Overview
12.3.3 Salivary Gland Infection Introduction
12.3.4 AstraZeneca (UK) Revenue in Salivary Gland Infection Business (2014-2019)
12.3.5 AstraZeneca (UK) Recent Development
12.4 FUJIFILM Holdings Corporation (Japan)
12.4.1 FUJIFILM Holdings Corporation (Japan) Company Details
12.4.2 Company Description and Business Overview
12.4.3 Salivary Gland Infection Introduction
12.4.4 FUJIFILM Holdings Corporation (Japan) Revenue in Salivary Gland Infection Business (2014-2019)
12.4.5 FUJIFILM Holdings Corporation (Japan) Recent Development
12.5 General Electric Company (US)
12.5.1 General Electric Company (US) Company Details
12.5.2 Company Description and Business Overview
12.5.3 Salivary Gland Infection Introduction
12.5.4 General Electric Company (US) Revenue in Salivary Gland Infection Business (2014-2019)
12.5.5 General Electric Company (US) Recent Development
12.6 GlaxoSmithKline plc. (UK)
12.6.1 GlaxoSmithKline plc. (UK) Company Details
12.6.2 Company Description and Business Overview
12.6.3 Salivary Gland Infection Introduction
12.6.4 GlaxoSmithKline plc. (UK) Revenue in Salivary Gland Infection Business (2014-2019)
12.6.5 GlaxoSmithKline plc. (UK) Recent Development
12.7 Johnson & Johnson Services, Inc. (US)
12.7.1 Johnson & Johnson Services, Inc. (US) Company Details
12.7.2 Company Description and Business Overview
12.7.3 Salivary Gland Infection Introduction
12.7.4 Johnson & Johnson Services, Inc. (US) Revenue in Salivary Gland Infection Business (2014-2019)
12.7.5 Johnson & Johnson Services, Inc. (US) Recent Development
12.8 Merck & Co., Inc. (US)
12.8.1 Merck & Co., Inc. (US) Company Details
12.8.2 Company Description and Business Overview
12.8.3 Salivary Gland Infection Introduction
12.8.4 Merck & Co., Inc. (US) Revenue in Salivary Gland Infection Business (2014-2019)
12.8.5 Merck & Co., Inc. (US) Recent Development
12.9 Pfizer Inc.(US)
12.9.1 Pfizer Inc.(US) Company Details
12.9.2 Company Description and Business Overview
12.9.3 Salivary Gland Infection Introduction
12.9.4 Pfizer Inc.(US) Revenue in Salivary Gland Infection Business (2014-2019)
12.9.5 Pfizer Inc.(US) Recent Development
12.10 Siemens Healthcare GmbH (Germany)
12.10.1 Siemens Healthcare GmbH (Germany) Company Details
12.10.2 Company Description and Business Overview
12.10.3 Salivary Gland Infection Introduction
12.10.4 Siemens Healthcare GmbH (Germany) Revenue in Salivary Gland Infection Business (2014-2019)
12.10.5 Siemens Healthcare GmbH (Germany) Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Salivary Gland Infection Key Market Segments
Table Key Players Salivary Gland Infection Covered
Table Global Salivary Gland Infection Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Salivary Gland Infection Market Size Market Share by Type 2014-2025
Figure Diagnosis Figures
Table Key Players of Diagnosis
Figure Treatment Figures
Table Key Players of Treatment
Table Global Salivary Gland Infection Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinic Case Studies
Figure Household Case Studies
Figure Other Case Studies
Figure Salivary Gland Infection Report Years Considered
Table Global Salivary Gland Infection Market Size 2014-2025 (Million US$)
Figure Global Salivary Gland Infection Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Salivary Gland Infection Market Size by Regions 2014-2025 (Million US$)
Table Global Salivary Gland Infection Market Size by Regions 2014-2019 (Million US$)
Table Global Salivary Gland Infection Market Share by Regions 2014-2019
Figure Global Salivary Gland Infection Market Share by Regions 2014-2019
Figure Global Salivary Gland Infection Market Share by Regions 2019
Table Market Top Trends
Table Global Salivary Gland Infection Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Salivary Gland Infection Market Share by Manufacturers (2014-2019)
Figure Global Salivary Gland Infection Market Share by Manufacturers in 2018
Table Global Salivary Gland Infection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Salivary Gland Infection Product/Solution/Service
Table Date of Enter into Salivary Gland Infection Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Salivary Gland Infection Market Size by Type (2014-2019) (Million US$)
Table Global Salivary Gland Infection Market Size Share by Type (2014-2019)
Figure Global Salivary Gland Infection Market Size Market Share by Type (2014-2019)
Table Global Salivary Gland Infection Market Size by Application (2014-2019) (Million US$)
Table Global Salivary Gland Infection Market Size Share by Application (2014-2019)
Figure Global Salivary Gland Infection Market Size Market Share by Application (2014-2019)
Figure Global Salivary Gland Infection Revenue Market Share by Application in 2018
Figure United States Salivary Gland Infection Market Size 2014-2019 (Million US$)
Table United States Key Players Salivary Gland Infection Revenue (2018-2019) (Million US$)
Table United States Key Players Salivary Gland Infection Market Share (2018-2019)
Table United States Salivary Gland Infection Market Size by Type (2014-2019) (Million US$)
Table United States Salivary Gland Infection Market Share by Type (2014-2019)
Table United States Salivary Gland Infection Market Size by Application (2014-2019) (Million US$)
Table United States Salivary Gland Infection Market Share by Application (2014-2019)
Figure Europe Salivary Gland Infection Market Size 2014-2019 (Million US$)
Table Europe Key Players Salivary Gland Infection Revenue (2018-2019) (Million US$)
Table Europe Key Players Salivary Gland Infection Market Share (2018-2019)
Table Europe Salivary Gland Infection Market Size by Type (2014-2019) (Million US$)
Table Europe Salivary Gland Infection Market Share by Type (2014-2019)
Table Europe Salivary Gland Infection Market Size by Application (2014-2019) (Million US$)
Table Europe Salivary Gland Infection Market Share by Application (2014-2019)
Figure China Salivary Gland Infection Market Size 2014-2019 (Million US$)
Table China Key Players Salivary Gland Infection Revenue (2018-2019) (Million US$)
Table China Key Players Salivary Gland Infection Market Share (2018-2019)
Table China Salivary Gland Infection Market Size by Type (2014-20189) (Million US$)
Table China Salivary Gland Infection Market Share by Type (2014-2019)
Table China Salivary Gland Infection Market Size by Application (2014-2019) (Million US$)
Table China Salivary Gland Infection Market Share by Application (2014-2019)
Figure Japan Salivary Gland Infection Market Size 2014-2019 (Million US$)
Table Japan Key Players Salivary Gland Infection Revenue (2018-2019) (Million US$)
Table Japan Key Players Salivary Gland Infection Market Share (2018-2019)
Table Japan Salivary Gland Infection Market Size by Type (2014-2019) (Million US$)
Table Japan Salivary Gland Infection Market Share by Type (2014-2019)
Table Japan Salivary Gland Infection Market Size by Application (2014-2019) (Million US$)
Table Japan Salivary Gland Infection Market Share by Application (2014-2019)
Figure Southeast Asia Salivary Gland Infection Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Salivary Gland Infection Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Salivary Gland Infection Market Share (2018-2019)
Table Southeast Asia Salivary Gland Infection Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Salivary Gland Infection Market Share by Type (2014-2019)
Table Southeast Asia Salivary Gland Infection Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Salivary Gland Infection Market Share by Application (2014-2019)
Figure India Salivary Gland Infection Market Size 2014-2019 (Million US$)
Table India Key Players Salivary Gland Infection Revenue (2018-2019) (Million US$)
Table India Key Players Salivary Gland Infection Market Share (2018-2019)
Table India Salivary Gland Infection Market Size by Type (2014-2019) (Million US$)
Table India Salivary Gland Infection Market Share by Type (2014-2019)
Table India Salivary Gland Infection Market Size by Application (2014-2019) (Million US$)
Table India Salivary Gland Infection Market Share by Application (2014-2019)
Figure Central & South America Salivary Gland Infection Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Salivary Gland Infection Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Salivary Gland Infection Market Share (2018-2019)
Table Central & South America Salivary Gland Infection Market Size by Type (2014-2019) (Million US$)
Table Central & South America Salivary Gland Infection Market Share by Type (2014-2019)
Table Central & South America Salivary Gland Infection Market Size by Application (2014-2019) (Million US$)
Table Central & South America Salivary Gland Infection Market Share by Application (2014-2019)
Table AbbVie Inc. (US) Company Details
Table AbbVie Inc. (US) Revenue in Salivary Gland Infection Business (2014-2019) (Million US$)
Figure AbbVie Inc. (US) Revenue Growth Rate in Salivary Gland Infection Business (2014-2019)
Table AbbVie Inc. (US) Recent Development
Table Allergan (Republic of Ireland) Company Details
Table Allergan (Republic of Ireland) Revenue in Salivary Gland Infection Business (2014-2019)(Million US$)
Figure Allergan (Republic of Ireland) Revenue Growth Rate in Salivary Gland Infection Business (2014-2019)
Table Allergan (Republic of Ireland) Recent Development
Table AstraZeneca (UK) Company Details
Table AstraZeneca (UK) Revenue in Salivary Gland Infection Business (2014-2019)(Million US$)
Figure AstraZeneca (UK) Revenue Growth Rate in Salivary Gland Infection Business (2014-2019)
Table AstraZeneca (UK) Recent Development
Table FUJIFILM Holdings Corporation (Japan) Company Details
Table FUJIFILM Holdings Corporation (Japan) Revenue in Salivary Gland Infection Business (2014-2019)(Million US$)
Figure FUJIFILM Holdings Corporation (Japan) Revenue Growth Rate in Salivary Gland Infection Business (2014-2019)
Table FUJIFILM Holdings Corporation (Japan) Recent Development
Table General Electric Company (US) Company Details
Table General Electric Company (US) Revenue in Salivary Gland Infection Business (2014-2019)(Million US$)
Figure General Electric Company (US) Revenue Growth Rate in Salivary Gland Infection Business (2014-2019)
Table General Electric Company (US) Recent Development
Table GlaxoSmithKline plc. (UK) Company Details
Table GlaxoSmithKline plc. (UK) Revenue in Salivary Gland Infection Business (2014-2019)(Million US$)
Figure GlaxoSmithKline plc. (UK) Revenue Growth Rate in Salivary Gland Infection Business (2014-2019)
Table GlaxoSmithKline plc. (UK) Recent Development
Table Johnson & Johnson Services, Inc. (US) Company Details
Table Johnson & Johnson Services, Inc. (US) Revenue in Salivary Gland Infection Business (2014-2019)(Million US$)
Figure Johnson & Johnson Services, Inc. (US) Revenue Growth Rate in Salivary Gland Infection Business (2014-2019)
Table Johnson & Johnson Services, Inc. (US) Recent Development
Table Merck & Co., Inc. (US) Company Details
Table Merck & Co., Inc. (US) Revenue in Salivary Gland Infection Business (2014-2019)(Million US$)
Figure Merck & Co., Inc. (US) Revenue Growth Rate in Salivary Gland Infection Business (2014-2019)
Table Merck & Co., Inc. (US) Recent Development
Table Pfizer Inc.(US) Company Details
Table Pfizer Inc.(US) Revenue in Salivary Gland Infection Business (2014-2019)(Million US$)
Figure Pfizer Inc.(US) Revenue Growth Rate in Salivary Gland Infection Business (2014-2019)
Table Pfizer Inc.(US) Recent Development
Table Siemens Healthcare GmbH (Germany) Company Details
Table Siemens Healthcare GmbH (Germany) Revenue in Salivary Gland Infection Business (2014-2019)(Million US$)
Figure Siemens Healthcare GmbH (Germany) Revenue Growth Rate in Salivary Gland Infection Business (2014-2019)
Table Siemens Healthcare GmbH (Germany) Recent Development
Table Global Salivary Gland Infection Market Size by Regions (Million US$) 2019-2025
Figure Global Salivary Gland Infection Market Size Share by Regions (2019-2025)
Figure Global Salivary Gland Infection Market Size Share by Regions in 2025
Figure United States Salivary Gland Infection Market Size Forecast (2019-2025)(Million USD)
Figure Europe Salivary Gland Infection Market Size Forecast (2019-2025)(Million USD)
Figure China Salivary Gland Infection Market Size Forecast (2019-2025)(Million USD)
Figure Japan Salivary Gland Infection Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Salivary Gland Infection Market Size Forecast (2019-2025)(Million USD)
Figure India Salivary Gland Infection Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Salivary Gland Infection Market Size Forecast (2019-2025)(Million USD)
Table Global Salivary Gland Infection Market Size by Product (2019-2025) (Million US$)
Figure Global Salivary Gland Infection Market Size by Product (2019-2025)
Figure Global Salivary Gland Infection Market Size by Product in 2025
Table Global Salivary Gland Infection Market Size by Application (2019-2025) (Million US$)
Figure Global Salivary Gland Infection Market Size by Application (2019-2025)
Figure Global Salivary Gland Infection Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources